Literature DB >> 11716560

Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.

A E Moore1, F Cicchetti, J Hennen, O Isacson.   

Abstract

In a model of Parkinson's disease (PD), amphetamine, a dopamine (DA)-releasing drug, fails to induce ipsilateral drug rotations in a proportion of rats with complete unilateral 6-hydroxydopamine (6-OHDA) lesions of the medial forebrain bundle and DA neurons of the substantia nigra. To investigate this phenomenon, individual 6-OHDA lesions (measured by tyrosine hydroxylase immunohistochemistry) in the substantia nigra pars compacta (A9), ventral tegmental area (A10), and striatum were examined in conjunction with outcomes of four behavioral tests. The behavioral tests were skilled paw reaching, a head-turning test, and apomorphine (0.05 mg/kg) and amphetamine (4 mg/kg) drug-induced rotations. Four weeks postlesion, ipsilateral side bias measured by the head-turning test correlated strongly with extent of A9 DA neuronal lesion. Additional A10 neuronal DA lesions did not substantially improve the model fit, indicating that the head-turning bias was primarily A9 dependent. In contrast, total head-turning activity increased monotonically with lesions of A10 striatal DA fibers. Skilled paw-reaching accuracy decreased with increased lesion of both A9 and A10 DA neuronal systems. Associating amphetamine-induced rotations with extent of A9 DA lesion generated a second-order polynomial model, y = -11.1x + 0.20 x(2) + 208.7 (R(2) = 0.73), with an overall F ratio (df = 2,21) of 28.4 (P < 0.0001). This model predicts that an A9 DA lesion of about 50% is required to induce an ipsilateral turning bias, after which rotations increase with the degree of A9 DA neuronal lesion. No further change in rotational behavior was seen until an additional A10 DA lesion reached 60%, after which the rotational response decreased. This analysis provides tests that differentiate between A9 DA degeneration and combined A9/A10 lesions in animal models and in addition allows predictive testing of PD therapeutic intervention at a preclinical level. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716560     DOI: 10.1006/exnr.2001.7823

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

1.  Orthotopic transplantation of immortalized mesencephalic progenitors (CSM14.1 cells) into the substantia nigra of hemiparkinsonian rats induces neuronal differentiation and motoric improvement.

Authors:  Stefan Jean-Pierre Haas; Stanislav Petrov; Golo Kronenberg; Oliver Schmitt; Andreas Wree
Journal:  J Anat       Date:  2007-11-23       Impact factor: 2.610

2.  Dissociable effects of disconnecting amygdala central nucleus from the ventral tegmental area or substantia nigra on learned orienting and incentive motivation.

Authors:  Heather El-Amamy; Peter C Holland
Journal:  Eur J Neurosci       Date:  2007-03       Impact factor: 3.386

3.  α-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration.

Authors:  Oleg S Gorbatyuk; Shoudong Li; Frederic Nha Nguyen; Fredric P Manfredsson; Galina Kondrikova; Layla F Sullivan; Craig Meyers; Weijun Chen; Ronald J Mandel; Nicholas Muzyczka
Journal:  Mol Ther       Date:  2010-07-27       Impact factor: 11.454

4.  Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons.

Authors:  Oliver Cooper; Ole Isacson
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

5.  A novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation.

Authors:  Patricia Vergara-Aragon; Claudia L R Gonzalez; Ian Q Whishaw
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

6.  Genetic dissection of midbrain dopamine neuron development in vivo.

Authors:  Debra Ellisor; Caroline Rieser; Bettina Voelcker; Jason T Machan; Mark Zervas
Journal:  Dev Biol       Date:  2012-10-04       Impact factor: 3.582

7.  Effects of development and dopamine depletion on striatal NMDA receptor-mediated calcium uptake.

Authors:  Thabelo Khoboko; Vivienne A Russell
Journal:  Metab Brain Dis       Date:  2007-06-27       Impact factor: 3.584

8.  Fate mapping and lineage analyses demonstrate the production of a large number of striatal neuroblasts after transforming growth factor alpha and noggin striatal infusions into the dopamine-depleted striatum.

Authors:  Antoine de Chevigny; Oliver Cooper; Angel Vinuela; Casper Reske-Nielsen; Diane C Lagace; Amelia J Eisch; Ole Isacson
Journal:  Stem Cells       Date:  2008-06-12       Impact factor: 6.277

9.  Transplanting intact donor tissue enhances dopamine cell survival and the predictability of motor improvements in a rat model of Parkinson's disease.

Authors:  Rosemary A Fricker; Jan Herman Kuiper; Monte A Gates
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

10.  High on habits.

Authors:  Monica R F Hilário; Rui M Costa
Journal:  Front Neurosci       Date:  2008-12-15       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.